|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
47,900,000 |
Market
Cap: |
53.65(M) |
Last
Volume: |
92,722 |
Avg
Vol: |
374,904 |
52
Week Range: |
$1.04 - $2.66 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P SMALLCAP 600 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Enzo Biochem is a diagnostics, clinical lab, and life sciences company. Co.'s operating segments include: Enzo Clinical Lab, which is a clinical reference laboratory providing a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies; Enzo Life Sciences, which manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide; Enzo Therapeutics, which is a biopharmaceutical venture that has developed multiple approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases, various of which are derived from the work of Enzo Life Sciences.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
417,900 |
Total Buy Value |
$0 |
$0 |
$0 |
$873,769 |
Total People Bought |
0 |
0 |
0 |
5 |
Total Buy Transactions |
0 |
0 |
0 |
14 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Harbert Raymond J |
10% Owner |
|
2021-03-15 |
4 |
S |
$5.00 |
$223,840 |
I/I |
(44,768) |
5,475,913 |
|
-6% |
|
Harbert Raymond J |
10% Owner |
|
2021-03-15 |
4 |
S |
$4.75 |
$475,000 |
I/I |
(100,000) |
5,520,681 |
|
-6% |
|
Rabbani Elazar |
CHIEF EXECUTIVE OFFICER |
|
2021-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
190,114 |
2,262,208 |
|
- |
|
Weiner Barry W |
PRESIDENT AND TREASURER |
|
2021-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
142,586 |
1,657,499 |
|
- |
|
Clemens Peter J IV |
10% Owner |
|
2020-02-18 |
4 |
B |
$2.20 |
$8,800 |
D/D |
4,000 |
15,000 |
2.37 |
2% |
|
Clemens Peter J IV |
10% Owner |
|
2020-02-14 |
4 |
B |
$2.21 |
$13,260 |
D/D |
6,000 |
11,000 |
2.37 |
2% |
|
Harbert Raymond J |
10% Owner |
|
2019-08-20 |
4 |
B |
$3.11 |
$30,167 |
I/I |
9,700 |
5,620,681 |
1.5 |
- |
|
Harbert Raymond J |
10% Owner |
|
2019-08-16 |
4 |
B |
$3.06 |
$69,768 |
I/I |
22,800 |
5,610,981 |
1.5 |
- |
|
Harbert Raymond J |
10% Owner |
|
2019-07-23 |
4 |
B |
$3.65 |
$1,493,580 |
I/I |
409,200 |
5,588,181 |
1.5 |
- |
|
Harbert Raymond J |
10% Owner |
|
2019-07-22 |
4 |
B |
$3.64 |
$35,104 |
I/I |
9,644 |
5,178,981 |
1.5 |
- |
|
Harbert Raymond J |
10% Owner |
|
2019-05-30 |
4 |
B |
$3.07 |
$59,530 |
I/I |
19,391 |
5,169,337 |
1.5 |
- |
|
Harbert Raymond J |
10% Owner |
|
2019-05-29 |
4 |
B |
$3.08 |
$58,674 |
I/I |
19,050 |
5,149,946 |
1.5 |
- |
|
Harbert Raymond J |
10% Owner |
|
2019-05-28 |
4 |
B |
$3.06 |
$41,852 |
I/I |
13,677 |
5,130,896 |
1.5 |
- |
|
Harbert Raymond J |
10% Owner |
|
2019-05-28 |
4 |
B |
$3.10 |
$155,000 |
I/I |
50,000 |
5,117,219 |
1.5 |
- |
|
Harbert Raymond J |
10% Owner |
|
2019-05-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,053,087 |
|
- |
|
Harbert Raymond J |
10% Owner |
|
2019-05-20 |
4 |
B |
$3.61 |
$51,017 |
I/I |
14,132 |
5,067,219 |
1.5 |
- |
|
Rabbani Elazar |
Chm of the Bd, CEO and Sec |
|
2019-01-14 |
4 |
OE |
$2.70 |
$7,511 |
D/D |
2,782 |
1,661,003 |
|
- |
|
Bortz Gregory M. |
Director |
|
2019-01-14 |
4 |
OE |
$2.70 |
$24,797 |
D/D |
9,184 |
93,699 |
|
- |
|
Weiner Barry W |
Pres, CFO Prin Acct Ofcr Treas |
|
2019-01-14 |
4 |
OE |
$2.70 |
$6,010 |
D/D |
2,226 |
1,136,918 |
|
- |
|
Perlysky Dov |
Director |
|
2019-01-14 |
4 |
OE |
$2.70 |
$24,797 |
D/D |
9,184 |
65,787 |
|
- |
|
Rabbani Elazar |
Chm of the Bd, CEO and Sec |
|
2018-10-29 |
4 |
B |
$3.35 |
$33,469 |
D/D |
10,000 |
1,848,668 |
2.81 |
- |
|
Perlysky Dov |
Director |
|
2018-10-18 |
4 |
B |
$3.50 |
$35,000 |
D/D |
10,000 |
266,235 |
2.39 |
- |
|
Hanna Bruce A. |
Director |
|
2018-10-18 |
4 |
B |
$3.52 |
$52,787 |
D/D |
15,000 |
37,816 |
2.39 |
- |
|
Perlysky Dov |
Director |
|
2018-04-13 |
4 |
A |
$0.00 |
$0 |
I/I |
81,855 |
779,692 |
|
- |
|
Perlysky Dov |
Director |
|
2018-04-12 |
4 |
A |
$0.00 |
$0 |
I/I |
3,139 |
697,837 |
|
- |
|
264 Records found
|
|
Page 3 of 11 |
|
|